PI-RADS: Where Next?

被引：23

作者：

Turkbey, Baris ^{[1
]}

Purysko, Andrei S. ^{[2
]}

机构：

[1] NCI, Mol Imaging Branch, NIH, 10 Ctr Dr,MSC 1182,Bldg 10,Room B3B85, Bethesda, MD 20892 USA

[2] Cleveland Clin, Sect Abdominal Imaging, Dept Nucl Radiol, Imaging Inst, Cleveland, OH USA

来源：

RADIOLOGY | 2023年 / 307卷 / 05期

关键词：

DIFFUSION-COEFFICIENT VALUES; SYSTEM VERSION 2; PROSTATE-CANCER; MRI; OUTCOMES; IMAGES; RISK; MEN;

D O I：

10.1148/radiol.223128

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Prostate MRI plays an important role in the clinical management of localized prostate cancer, mainly assisting in biopsy decisions and guiding biopsy procedures. The Prostate Imaging Reporting and Data System (PI-RADS) has been available to radiologists since 2012, with the most up-to-date and actively used version being PI-RADS version 2.1. This review article discusses the current use of PIRADS, including its limitations and controversies, and summarizes research that aims to improve future iterations of this system.

引用

页数：13